Zimmer Biomet (ZBH) Short Interest Ratio & Short Volume

Short interest is the volume of Zimmer Biomet shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 6,220,000 shares of ZBH short. 3.13% of Zimmer Biomet's shares are currently sold short. Learn More on Zimmer Biomet's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZBH shares currently have a short interest ratio of 3.0. Learn More on Zimmer Biomet's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Zimmer Biomet: Wolverine Trading LLC, Squarepoint Ops LLC, Millennium Management LLC, Group One Trading LLC, Cubist Systematic Strategies LLC, Citadel Advisors LLC, Capstone Investment Advisors LLC, BNP Paribas Financial Markets, Jane Street Group LLC, Tudor Investment Corp ET AL, Boothbay Fund Management LLC, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Pura Vida Investments LLC, JPMorgan Chase & Co., IMC Chicago LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.13% of Zimmer Biomet's floating shares are currently sold short.

Zimmer Biomet saw a drop in short interest in March. As of March 15th, there was short interest totaling 6,220,000 shares, a drop of 11.8% from the previous total of 7,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Zimmer Biomet currently has issued a total of 199,063,000 shares. Some of Zimmer Biomet's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Zimmer Biomet currently has a public float of 198,690,000 shares.

3.13% of Zimmer Biomet's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Zimmer Biomet: GE HealthCare Technologies Inc. (2.15%), Koninklijke Philips (0.20%), Solventum Co. (3.14%), Smith & Nephew plc (0.26%), Penumbra, Inc. (3.33%), Stevanato Group S.p.A. (6.75%), Glaukos Co. (7.21%), Bausch + Lomb Co. (5.63%), Inspire Medical Systems, Inc. (10.19%), Inari Medical, Inc. (4.24%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

Short selling ZBH is an investing strategy that aims to generate trading profit from Zimmer Biomet as its price is falling. ZBH shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Zimmer Biomet occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZBH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZBH, twice per month. The most recent reporting period available is March, 15 2025.